Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/24/1992 | EP0403503A4 Nucleic acid isolation |
06/24/1992 | EP0207963B1 Monoclonal antibodies and antigen for human non-small cell lung carcinomas |
06/24/1992 | CN1062172A Ribosome-inactivating proteins, inactive precursor forms thereof, process for making and method of using |
06/24/1992 | CN1062170A Method for expressing outside source gene by domestic silkworm larva chrysalis |
06/24/1992 | CN1062169A Pichia pastoris acid phosphatae gene |
06/24/1992 | CN1062168A Chicken anemia virus vaccine and diagnostic |
06/23/1992 | WO1992011362A1 Serotonine receptor of class 1: the 5-ht1x receptors |
06/23/1992 | US5124504 Nitrate-tolerant soybean |
06/23/1992 | US5124440 Antibody and T cell recognition sites on glycoproteins comprising the GCI complex of human cytomegalovirus |
06/23/1992 | US5124264 Monoclonal antibody recognizing atrial natriuretic polypeptide |
06/23/1992 | US5124263 Recombination resistant retroviral helper cell and products produced thereby |
06/23/1992 | US5124261 Using genetic engineering technique comprising heat treating a host cell having the aqualysin precursor in a culture medium, and recovering the aqualysin |
06/23/1992 | US5124260 Directs stable integration of DNA segment or selectable marker to defined nonessential site |
06/23/1992 | US5124259 Suspenion of cells and Dna in potassium salt of (amino)acids; applying voltage |
06/23/1992 | US5124257 Method for preparing l-alanine |
06/23/1992 | US5124255 CKS method of protein synthesis |
06/23/1992 | US5124248 Medical diagnosis; immunoassay |
06/23/1992 | US5124153 Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products |
06/23/1992 | CA2098706A1 5-ht1x receptor |
06/23/1992 | CA1304026C Vector and method for achieving high level expression in eukaryotic cells |
06/23/1992 | CA1304025C Modified zein |
06/23/1992 | CA1304024C Covalently linked polypeptide cell modulators |
06/23/1992 | CA1304023C .beta.-UROGASTRONE GENE, CORRESPONDING RECOMBINANT PLASMIDS, CORRESPONDING TRANSFORMANTS AND PREPARATION THEREOF AND OF .beta.-UROGASTRONE |
06/23/1992 | CA1304022C Insulin precursors, process for their preparation and process for preparing human insulin from such insulin precursors |
06/23/1992 | CA1304021C Microbiological process for the preparation of a protein by culturing a mutant bacterial strain |
06/23/1992 | CA1304020C High level expression in yeast |
06/22/1992 | WO1992011387A1 Diagnosis for porcine malignant hyperthermia |
06/22/1992 | WO1992011374A1 DNA SEQUENCES ENCODING AT LEAST PART OF THE TOMATO ENZYME ENDOPOLYGALACTURONASE PG1 β-SUBUNIT |
06/22/1992 | WO1992011364A1 Biosynthetic pdgf antagonists |
06/22/1992 | WO1992011348A1 Enzymes and enzymatic detergent compositions |
06/22/1992 | WO1992011286A1 Oxidation resistant variants of parathyroid hormone |
06/22/1992 | CA2098837A1 Dna sequences encoding at least part of the tomato enzyme endopolygalacturonase pg1 .beta.-subunit |
06/22/1992 | CA2098703A1 Enzymes and enzymatic detergent compositions |
06/22/1992 | CA2098283A1 Oxidation resistant variants of parathyroid hormone |
06/22/1992 | CA2097603A1 Biosynthetic pdgf antagonists |
06/22/1992 | CA2079702A1 Diagnosis for porcine malignant hyperthermia |
06/22/1992 | CA2058379A1 Babesial protease antigen |
06/22/1992 | CA2058280A1 Expression systems |
06/21/1992 | WO1992011273A1 Pcr primers for detection of legionella species and methods for controlling visual intensity in hybridization assays |
06/21/1992 | WO1992011272A1 Optimization of binding proteins |
06/21/1992 | WO1992011120A1 Method and apparatus for granulation |
06/21/1992 | CA2098824A1 Optimization of binding proteins |
06/21/1992 | CA2098600A1 Method and apparatus for granulation |
06/21/1992 | CA2075493A1 Pcr primers for detection of legionella species and methods for controlling visual intensity in hybridization assays |
06/20/1992 | WO1992011378A1 A method of constructing synthetic leader sequences |
06/20/1992 | WO1992011018A1 Improved humanized immunoglobulins |
06/20/1992 | CA2098731A1 Method of constructing synthetic leader sequences |
06/20/1992 | CA2057715A1 Method for enhancing the structural stability of recombinant dna expression vectors |
06/19/1992 | WO1992011377A1 Tissue plasminogen activator substitution variant |
06/19/1992 | WO1992011360A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
06/19/1992 | CA2098484A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
06/19/1992 | CA2057951A1 Chimeric antibodies and their use |
06/19/1992 | CA2057842A1 Human monoclonal antibody |
06/17/1992 | EP0490410A1 TXA2 Receptor and gene encoding the same |
06/17/1992 | EP0490233A1 Monoclonal antibodies against Bgl III-hybrid interferons, their use and process for preparing them |
06/17/1992 | EP0490077A1 Antisense oligonucleotides for treatment of cancer |
06/17/1992 | EP0489868A1 Transgenic animal model for viral infections |
06/17/1992 | EP0489846A1 Antisense oligonucleotides to c-abl proto-oncogene |
06/17/1992 | EP0489830A1 Expression of alpha-macroglobulins |
06/17/1992 | EP0489822A1 Abo genotyping |
06/17/1992 | EP0489780A1 Fusion proteins, their preparation and use |
06/17/1992 | EP0485608A4 Method for obtaining polypeptides in a cell-free translation system |
06/17/1992 | EP0484411A4 Prevention of internal initiation |
06/17/1992 | EP0479922A4 Monoclonal antibodies to c-reactive protein |
06/17/1992 | EP0467953A4 Improved primer extension reactions |
06/17/1992 | EP0215131B1 E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma |
06/17/1992 | DE4105374C1 New hybridoma Han-41 and its corresp. antibody - recognise glyco-protein found in broncho-alveolar system; useful as cell differentiation markers and to classify human lung |
06/17/1992 | DE4040043A1 New acid-stable and infectious human rhinovirus mutant - prepd. by incubating wild type virus at varying pH, useful for treating rhinoviral infection |
06/17/1992 | CN1062002A Protease |
06/17/1992 | CN1062001A Silkworm method for efficient expressing protein of chinese trichosanthes root and other useful proteins |
06/16/1992 | US5122600 Using a carrier of specific particle size and one which does not absorb protein |
06/16/1992 | US5122599 CDNAS coding for members of the carcinoembryonic antigen family |
06/16/1992 | US5122595 Modulates expression of extracellular enzymes in Streptomyces |
06/16/1992 | US5122594 Having specific arginines replaced by glutamine and/or serine |
06/16/1992 | US5122466 Ballistic transformation of conifers |
06/16/1992 | US5122465 Strains of pichia pastoris created by interlocus recombination |
06/16/1992 | US5122464 Method for dominant selection in eucaryotic cells |
06/16/1992 | US5122463 Methods for trans-destabilization of specific proteins in vivo and dna molecules useful therefor |
06/16/1992 | US5122459 Gene encoding biologically active human interleukin 1 |
06/16/1992 | US5122458 Use of a bgh gdna polyadenylation signal in expression of non-bgh polypeptides in higher eukaryotic cells |
06/16/1992 | US5122457 Expression systems utilizing bacteriophage t7 promoters, gene sequences, and t7 rna polymerase |
06/16/1992 | CA1303534C Human anti-rh(d) monoclonal antibodies |
06/16/1992 | CA1303533C Human anti-rh(d) monoclonal antibodies |
06/16/1992 | CA1303532C Determination of fibrin using fibrin-specific antibodies |
06/16/1992 | CA1303531C Choriocarcinoma monoclonal antibodies and antibody panels |
06/16/1992 | CA1303530C EXPRESSION VECTORS AND THEIR USE FOR THE PREPARATION OF A PROTEIN HAVING HUMAN .alpha. -ANTITRYPSIN ACTIVITY |
06/16/1992 | CA1303529C Human interferon- _polypeptide derivative |
06/16/1992 | CA1303527C Cross-over linker dna sequence |
06/16/1992 | CA1303525C Rotavirus reassortant vaccine |
06/15/1992 | WO1992010506A1 Human retrovirus receptor and dna coding therefor |
06/15/1992 | CA2097705A1 Human retrovirus receptor and dna coding therefor |
06/14/1992 | WO1992010577A1 Multisite integration cassette for the genome of a yeast |
06/14/1992 | WO1992010576A1 Fusion polypeptides |
06/14/1992 | WO1992010570A1 Leukemia inhibitory factor receptors |
06/14/1992 | WO1992010564A1 Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy |
06/14/1992 | CA2098510A1 Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy |
06/14/1992 | CA2098304A1 Multisite integration cassette for the genome of a yeast |
06/14/1992 | CA2097291A1 Leukemia inhibitory factor receptors |
06/14/1992 | CA2094512A1 Fusion polypeptides |
06/11/1992 | WO1992010582A1 Monokine mig induced by ifn-gamma |